Clinical trial
Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
NCT00002794 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00002794 |
|---|---|
| Title | Carboplatin Plus Vincristine in Treating Children With Retinoblastoma |
| Official title | Evaluation of Chemotherapy as Initial Treatment for Retinoblastoma |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Retinoblastoma |
| Intervention type | Drug |
| Interventions | carboplatin, vincristine sulfate |
| Enrollment | 25 |
| Start date | Feb 1, 1996 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Apr 26, 2004 |
| Last update posted | Oct 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: